Erratum.

In the article "Extracorporeal Blood Purification with the oXiris® Filter for Patients with Sepsis and Hyperinflammatory Conditions: The Asia-Pacific oXiris Expert Meeting 2024 Consensus Statements" [Blood Purif. 2025;54(11):621-638; https://doi.org/10.1159/000548214] by Zhang et al., the authors noticed there was an error in Figure 1.Fig. 1.Treatment algorithm for oXiris filter use in patients needing CRRT with sepsis/septic shock, severe COVID-19 or other hyperinflammatory states. AKI, acute kidney injury; APACHE, Acute Physiology and Chronic Health Evaluation; CRP, C-reactive protein; CRRT, continuous renal replacement therapy; CVVH, continuous veno-venous hemofiltration; CVVHD, continuous veno-venous hemodialysis; CVVHDF, continuous veno-venous hemodiafiltration; EAA, endotoxin activity assay; ECMO, extracorporeal membrane oxygenation; HIT, heparin-induced thrombocytopenia; SOFA, Sequential Organ Failure Assessment; KDIGO, Kidney Disease: Improving Global Outcomes; PCT, procalcitonin; IL, interleukin; PaO2/FiO2, partial pressure-to-fractional inspired oxygen ratio; SCUF, slow continuous ultrafiltration; TNF, tumor necrosis factor.In the "Failure" column of the "Evaluate treatment success/failure" section, the figure originally stated: "Improvement in hemodynamic parameters/dependence on vasopressors after 72 hours." The word "No" was inadvertently omitted at the beginning of this criterion. The correct statement should read: "No improvement in hemodynamic parameters/dependence on vasopressors after 72 hours."The error was introduced during the preparation of the figure. The correct wording has been verified by cross-referencing the figure with Statement 5.1 in the main text (p. 630) and Table 1 (p. 625), both of which consistently and correctly state the treatment futility criterion as: "No improvement in hemodynamic parameters/dependence on vasopressors after 72 hours." The corrected Figure 1 is shown below.